First Human Dosimetry Study Validates Radiation Profile of Astrogliosis PET Tracer [18F]SMBT-1
A human clinical trial reveals that the reactive astrogliosis PET tracer SMBT-1 displays an effective radiation dose comparable to established ...
A human clinical trial reveals that the reactive astrogliosis PET tracer SMBT-1 displays an effective radiation dose comparable to established ...
The study, published in EJNMMI Radiopharmacy and Chemistry, utilized two distinct radiotracers: In-PSMA-I&T for targeting PSMA-positive lesions and Tc-DPD for ...
A new crosslinked polyionic complex micelle platform stabilizes indium-111 within its core, enhancing tumor accumulation and systemic circulation in mouse ...
Researchers established an integrated reactor production workflow using thin-layer gadolinium-160 chloride targets and direct hydrochloric acid extraction chromatography to generate ...
A pilot feasibility study demonstrated that pretherapeutic quantitative I-131 SPECT/CT provides reliable blood and tumour dosimetry in poorly differentiated thyroid ...
Ahead-of-print studies in The Journal of Nuclear Medicine report advances in targeted radiotheranostics, molecular imaging of kidney fibrosis, and clinical ...
A study in EJNMMI Research finds that metabolic tumor volume from FDOPA PET/CT correlates with angioinvasion and catecholamine levels in ...
A scoping review of Turkish literature indicates that FAP-targeted PET/CT functions as a selective, question-driven imaging tool rather than a ...
A virtual-patient modelling framework identifies a robust 33-to-67-hour imaging window centered at 50 hours that minimizes both population errors and ...
FDG PET/CT revealed rare central and peripheral neurolymphomatosis in two DLBCL patients who both died shortly after imaging.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine